Quality control of pharmaceutical formulations containing cisplatin, carboplatin, and oxaliplatin by micellar and microemulsion electrokinetic chromatography (MEKC, MEEKC)

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 2, 2011, Pages 253-258

  Nussbaumer, Susanne ^a,b   Fleury Souverain, Sandrine ^a   Schappler, Julie ^b   Rudaz, Serge ^b   Veuthey, Jean Luc ^b   Bonnabry, Pascal ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Anticancer drugs; Capillary electrophoresis; Micellar electrokinetic chromatography (MEKC); Platinum drugs; Quality control; Validation

Indexed keywords

CARBOPLATIN; CISPLATIN; EBEWE; OXALIPLATIN; TEVA; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; DRUG QUALITY; DRUG STRUCTURE; ELECTRIC POTENTIAL; HYDRODYNAMICS; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; MICROEMULSION ELECTROKINETIC CHROMATOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; ULTRAVIOLET RADIATION; UNIVERSITY HOSPITAL; VALIDITY;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CHROMATOGRAPHY; CHROMATOGRAPHY, MICELLAR ELECTROKINETIC CAPILLARY; CISPLATIN; EMULSIONS; MICELLES; ORGANOPLATINUM COMPOUNDS; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 79952248435     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.01.029     Document Type: Article

References (31)

1. Thurston D.E. Chemistry and Pharmacology of Anticancer Drugs 2007, CRC Press Taylor and Francis Group, Boca Raton.
2. Espinosa Bosch M., Ruiz Sánchez A.J., Sánchez Rojas F., Bosch Ojeda C. Analytical methodologies for the determination of cisplatin. J. Pharm. Biomed. Anal. 2008, 47:451-459.
3. Timerbaev A.R., Küng A., Keppler B.K. Capillary electrophoresis of platinum-group elements: analytical, speciation and biochemical studies. J. Chromatogr. A 2002, 945:25-44.
4. Hartinger C.G., Timerbaev A.R., Keppler B.K. Capillary electrophoresis in anti-cancer metallodrug research: advances and future challenges. Electrophoresis 2003, 24:2023-2037.
5. Hartinger C.G., Keppler B.K. CE in anticancer metallodrug research - an update. Electrophoresis 2007, 28:3436-3446.
6. Terabe S. Micellar electrokinetic chromatography for high-performance analytical separation. Chem. Rec. 2008, 8:291-301.
7. Schappler J., Guillarme D., Prat J., Veuthey J.-L., Rudaz S. Coupling CE with atmospheric pressure photoionization MS for pharmaceutical basic compounds: optimization of operating parameters. Electrophoresis 2007, 28:3078-3087.
8. Ryan R., Donegan S., Power J., Altria K. Advances in the theory and application of MEEKC. Electrophoresis 2010, 31:755-767.
9. Huang Z., Timerbaev A.R., Keppler B.K., Hirokawa T. Determination of cisplatin and its hydrolytic metabolite in human serum by capillary electrophoresis techniques. J. Chromatogr. A 2006, 1106:75-79.
10. Timerbaev A.R., Hartinger C.G., Aleksenko S.S., Keppler B.K. Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology. Chem. Rev. 2006, 106:2224-2248.
11. Rudnev A.V., Aleksenko S.S., Semenova O., Hartinger C.G., Timerbaev A.R., Keppler B.K. Determination of binding constants and stoichiometries for platinum anticancer drugs and serum transport proteins by capillary electrophoresis using the Hummel-Dreyer method. J. Sep. Sci. 2005, 28:121-127.
12. Groessl M., Hartinger C.G., Polec-Pawlak K., Jarosz M., Keppler B.K. Capillary electrophoresis hyphenated to inductively coupled plasma-mass spectrometry: a novel approach for the analysis of anticancer metallodrugs in human serum and plasma. Electrophoresis 2008, 29:2224-2232.
13. Lemma T., Pawliszyn J. Human serum albumin interaction with oxaliplatin studied by capillary isoelectric focusing with the whole column imaging detection and spectroscopic method. J. Pharm. Biomed. Anal. 2009, 50:570-575.
14. Timerbaev A.R., Aleksenko S.S., Polec-Pawlak K., Ruzik R., Semenova O., Hartinger C.G., Oszwaldowski S., Galanski M., Jarosz M., Keppler B.K. Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin. Electrophoresis 2004, 25:1988-1995.
15. Küng A., Zenker A., Galanski M., Keppler B.K. Capillary electrophoretic study of carboplatin and analogues with nucleoside monophosphates, di- and trinucleotides. J. Inorg. Biochem. 2001, 83:181-186.
16. Zenker A., Galanski M., Bereuter T.L., Keppler B.K., Lindner W. Capillary electrophoretic study of cisplatin interaction with nucleoside monophosphates, di- and trinucleotides. J. Chromatogr. A 1999, 852:337-346.
17. Zenker A., Galanski M., Bereuter T.L., Keppler B.K., Lindner W. Kinetics of binding properties of 5′-GMP with cisplatin under simulated physiological conditions by capillary electrophoresis. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2000, 745:211-219.
18. Hartinger C.G., Schluga P., Galanski M., Baumgartner C., Timerbaev A.R., Keppler B.K. Tumor-inhibiting platinum(II) complexes with aminoalcohol ligands: comparison of the mode of action by capillary electrophoresis and electrospray ionization-mass spectrometry. Electrophoresis 2003, 24:2038-2044.
19. 7 chelation. Chembiochem 2004, 5:1543-1549.
20. Oszwaldowski S., Timerbaev A.R. Development of quantitative structure-activity relationships for interpretation of the migration behavior of neutral platinum(II) complexes in microemulsion electrokinetic chromatography. J. Chromatogr. A 2007, 1146:258-263.
21. Rappel C., Galanski M., Yasemi A., Habala L., Keppler B.K. Analysis of anticancer platinum(II)-complexes by microemulsion electrokinetic chromatography: separation of diastereomers and estimation of octanol-water partition coefficients. Electrophoresis 2005, 26:878-884.
22. Bytzek A.K., Reithofer M.R., Galanski M., Groessl M., Keppler B.K., Hartinger C.G. The first example of MEEKC-ICP-MS coupling and its application for the analysis of anticancer platinum complexes. Electrophoresis 2010, 31:1144-1150.
23. Wenclawiak B.W., Wollmann M. Separation of platinum(II) anti-tumour drugs by micellar electrokinetic capillary chromatography. J. Chromatogr. A 1996, 724:317-326.
24. Henchoz Y., Romand S., Schappler J., Rudaz S., Veuthey J.-L., Carrupt P.-A. High-throughput logP determination by MEEKC coupled with UV and MS detections. Electrophoresis 2010, 31:952-964.
25. Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. Validation des procédures analytiques quantitatives - harmonisation des démarches. STP Pharma Pratiques 2003, 13:101-138.
26. Tyagi P., Gahlot P., Kakkar R. Structural aspects of the anti-cancer drug oxaliplatin: a combined theoretical and experimental study. Polyhedron 2008, 27:3567-3574.
27. Schluga P., Hartinger C.G., Galanski M., Meelich K., Timerbaev A.R., Keppler B.K. Tumour-inhibiting platinum (II) complexes with aminoalcohol ligands: biologically important transformations studied by micellar electrokinetic chromatography, nuclear magnetic resonance spectroscopy and mass spectrometry. Analyst 2005, 130:1383-1389.
28. Cherkaoui S, Mateus L., Christen P., Veuthey J.-L. Micellar electrokinetic capillary chromatography for selected tropane alkaloid analysis in plant extract. Chromatographia 1997, 46:351-357.
29. Ortner K., Buchberger W., Himmelsbach M. Capillary electrokinetic chromatography of insulin and related synthetic analogues. J. Chromatogr. A 2009, 1216:2953-2957.
30. Rozet E., Ceccato A., Hubert C., Ziemons E., Oprean R., Rudaz S., Boulanger B., Hubert P. Analysis of recent pharmaceutical regulatory documents on analytical method validation. J. Chromatogr. A 2007, 1158:111-125.
31. Geiser L., Rudaz S., Veuthey J.-L. Decreasing analysis time in capillary electrophoresis: validation and comparison of quantitative performances in several approaches. Electrophoresis 2005, 26:2293-2302.